Home >> Content

Moulder Center Alumni

Class of 2020

Dr. Peng-Jen Chen received her Ph.D. in medicinal chemistry from Temple School of Pharmacy's Department of Pharmaceutical Science based on her work in the Moulder Center for Drug Discovery Research. During her time at the Moulder Center, she worked with her advisor, Dr. Benjamin E Blass, to design, synthesize, and evaluate novel D3 receptor modulators as potential therapies for cocaine addiction.  She is currently a post-doctoral scientist at Baylor College of Medicine

Dr. Elizabeth Hewlett received her Ph.D. in medicinal chemistry from Temple School of Pharmacy's Department of Pharmaceutical Science based on her work in the Moulder Center for Drug Discovery Research. During her time at the Moulder Center, she worked with her advisor, Dr. Wayne E. Childers, on the synthesis of a decalin based natural product found to inhibit the Rad52 complex.  She is currently a post-doctoral scientist at the Moulder Center for Drug Discovery Research.

Class of 2019

Dr. Kevin M Blattner received his Ph.D. in medicinal chemistry from Temple School of Pharmacy's Department of Pharmaceutical Science based on his work in the Moulder Center for Drug Discovery Research. During his time at the Moulder Center, he worked with his co-advisors Dr. Daniel J Canney and Dr, Benjamin E Blass to develop novel 5-HT7 modulators. He is currently a post-doctoral scientist with Praeventix, LLC, a Temple University spin-out company focused on the development of novel 5-HT7 modulators for the treatment of various disease states.

Class of 2017

Dr. Nicole Lounsbury received her Ph.D. in medicinal chemistry from Temple School of Pharmacy's Department of Pharmaceutical Science based on her work in the Moulder Center for Drug Discovery Research. During her time at the Moulder Center, she worked with her advisor, Dr. Wayne E Childers, on the synthesis and evaluation of Nrf2 activators.  She is currently an assistant professor in Larkin University School of Pharmacy's department of pharmaceutical science.

Dr. Rong Fan received her Ph.D. in medicinal chemistry Temple School of Pharmacys' Moulder Center for Drug Discovery Research. During her time at the Moulder Center, she worked with her advisor, Dr. Wayne E Childers, on  the design, synthesis, and evaluation of prodrugs for 5-Lypoxygenase (5-LO) inhibitors for Alzheimer’s Disease.  She is currently working as a research scientist at Frontage Laboratories in Exton, PA.

Dr. Aisha Al Ashmawy received her Ph.D. in medicinal chemistry through a program jointly run by Temple University School of Pharmacy and Cairo University.  Her research on novel inhibitors of  PI3Kα, a kinase implicated in cancer progression, was conducted under the direction of Dr. Magid Abou-Gharbia (Temple School of Pharmacy. Moulder Center for Drug Discovery Research), Dr. Wayne Childers (Temple School of Pharmacy. Moulder Center for Drug Discovery Research), and Dr. Fatima Ragab (Cairo University School of Pharmacy).  She is currently a Senior Research Scientist at Therapeutic Chemistry Department, National Research Center NRCHer, Cairo, Egypt. (aisha_pharmacy@yahoo.com)

Class of 2012

Dr. Siva Kumar Annadurai received his Ph.D. Pharmaceutical Sciences, (Medicinal Chemistry) from Temple University School of Pharmacy under the guidance’s of Dr. Daniel Canney and Dr. Magid Abou-Gharbia. His PhD thesis was titled “Lead generation using a privileged structure-based approach” and was focused on the preparation and evaluation of 2-aminothiazoles as modulators of various biological targets. He is currently an Assistant Professor of Pharmaceutical Sciences at King Khalid University in Saudi Arabia (medchemsiva@gmail.com).

Post-Doctoral Fellows:

Dr. Iman Saber (June 2019-present) joined Temple University School of Pharmacy’s Moulder Center to support an active research program focused on the evaluation of small molecule GLT-1 modulators in animal models of drug addiction and pain.  Prior to her roles a post-doctoral scientist, she received her PhD from the department of pharmaceutical science at Temple School of Pharmacy under the direction of Dr. Ellen Walker.

Dr. Aisha Al Ashmawy (March 2020-present) joined Temple University School of Pharmacy’s Moulder Center as a post-doctoral fellow under the USAID Fellowship Program and has is contributing to a program focused on the identification of novel PI3Kα/mTOR dual inhibitors useful for the treatment of cancer.  She is also a senior research scientist at the Therapeutic Chemistry Department, National Research Center NRCHer, Cairo, Egypt.

Dr. JohnPatrick Rogers (November 2017-September 2018) joined Temple University School of Pharmacy’s Moulder Center to support active research programs focused on the identification of novel cancer agents by designing and synthesizing novel compounds. Prior to joining Temple School of Pharmacy, Dr. Rogers was a post-doctoral scientist with Janssen Pharmaceuticals and GSK, and he received his PhD in organic chemistry from the University of California Davis,

Dr. Sivakumar Annadurai (May 2012-January 2014) joined Temple University School of Pharmacy’s Moulder Center to support a program focused on the identification of novel 5-Lipoxygenase (5-LO) inhibitors that could be used as PET tracers in brain imaging studies. Prior to his post-doctoral work, he received his PhD from Temple University School of Pharmacy under the guidance’s of Dr. Daniel Canney and Dr. Magid Abou-Gharbia. He is currently Assistant Professor of Pharmacognosy at College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

Dr. Victor Ghidu (June 2009- May 2015) joined Temple University School of Pharmacy’s Moulder Center to support active research programs on the identification of novel PCSK-9 inhibitors, GLT-1 expression modulators, and an improved process for the scale-up of the anxiolytic agent CL285032. During his tenure at Temple School of Pharmacy, he enrolled in Temple Law School and received his law degree in 2015.  Prior to joining Temple School of Pharmacy, Dr. Ghidu received his PhD in organic chemistry from Vanderbilt University under the direction of Dr. Gary Sulikowski.

Visiting Scholars

Dr. Siham Al Qaradawi (2010-2012) joined Temple University School of Pharmacy’s Moulder Center as a Fulbright Scholar in 2010 during her tenure as the dean of College of Arts & Sciences, Qatar University. She conducted research on the design, synthesis, and evaluation of novel GLT-1 expression enhancers in collaboration with scientist at the Moulder Center.  After completing her tenure as a Fulbright Scholar at Temple School of Pharmacy, she Fellow of the Royal Society of Chemistry and is currently a professor of chemistry at the College of Arts and Sciences, Qatar University, Doha Qatar.

Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140